Medtronic announces cash dividend for second quarter of fiscal year 2025

Rhea-AI Summary

Medtronic plc (NYSE:MDT), a leading global healthcare technology company, has announced its cash dividend for the second quarter of fiscal year 2025. The board of directors approved a dividend of $0.70 per ordinary share, consistent with the increase announced in May 2024. This decision reinforces Medtronic's status as an S&P 500 Dividend Aristocrat, having increased its annual dividend for 47 consecutive years.

The dividend is payable on October 11, 2024, to shareholders of record as of September 27, 2024. Medtronic, headquartered in Galway, Ireland, employs over 95,000 people across 150+ countries and focuses on addressing challenging health problems through innovative technologies and therapies.

Positive

• Maintained consistent quarterly dividend of $0.70 per share
• 47 consecutive years of annual dividend increases
• Inclusion in S&P 500 Dividend Aristocrats index

Negative

• None.

Financial Analyst

Medtronic's consistent dividend payment underscores its financial stability and commitment to shareholder returns. The $0.70 per share quarterly dividend aligns with the company's previous announcement, demonstrating reliability in executing its financial strategy. As a Dividend Aristocrat, Medtronic's 47-year streak of dividend increases is a strong indicator of its sustained profitability and cash flow generation. This consistency is particularly noteworthy in the healthcare technology sector, where companies often prioritize reinvestment over dividends. For investors, this represents a steady income stream and signals management's confidence in future cash flows. However, it's important to consider that while dividends are attractive, they may limit funds available for R&D or acquisitions in this innovation-driven industry.

Market Research Analyst

Medtronic's position as the leading global healthcare technology company is reinforced by its diverse portfolio addressing 70 health conditions. This breadth provides resilience against market fluctuations in specific medical segments. The company's global presence across 150+ countries offers geographical diversification, potentially mitigating regional economic risks. With 95,000+ employees, Medtronic has significant human capital to drive innovation and market expansion. The focus on high-growth areas like surgical robotics and patient monitoring systems aligns with emerging healthcare trends, positioning the company for potential long-term growth. Investors should monitor how Medtronic balances its dividend commitments with investments in these cutting-edge technologies to maintain its market leadership.

GALWAY, Ireland, Aug. 16, 2024 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 15, 2024, approved the company's cash dividend for the second quarter of fiscal year 2025 of $0.70 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2024. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 47 consecutive years. The dividend is payable on October 11, 2024, to shareholders of record at the close of business on September 27, 2024.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow Medtronic on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:
Erika Winkels	Ryan Weispfenning
Public Relations	Investor Relations
+1-763-526-8478	+1-763-505-4626

View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-announces-cash-dividend-for-second-quarter-of-fiscal-year-2025-302224139.html

SOURCE Medtronic plc

FAQ

What is Medtronic's (MDT) dividend for Q2 fiscal year 2025?

Medtronic's dividend for the second quarter of fiscal year 2025 is $0.70 per ordinary share.

When will Medtronic (MDT) pay its Q2 FY2025 dividend?

Medtronic will pay its Q2 FY2025 dividend on October 11, 2024, to shareholders of record as of September 27, 2024.

How many consecutive years has Medtronic (MDT) increased its annual dividend?

Medtronic has increased its annual dividend payment for 47 consecutive years.

Is Medtronic (MDT) part of the S&P 500 Dividend Aristocrats index?

Yes, Medtronic is a constituent of the S&P 500 Dividend Aristocrats index.